{"id":"W2518117171","doi":"10.1080/17474086.2016.1232163","title":"Ponatinib in the therapy of chronic myeloid leukemia","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Magic bullet; Myeloid leukemia; Targeted therapy; Disease; Oncology; Tyrosine-kinase inhibitor; Nilotinib; Internal medicine; Immunology; Bioinformatics; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008614798,0.0006556262,0.006493868,0.0002624915,0.00002366292,0.000002298066,0.0007613556,0.000465674,0.001315688],"category_scores_gemma":[0.000388767,0.0003043757,0.001217368,0.0005196742,0.0003158264,0.00003919958,0.0001020027,0.0004809356,0.00015422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001488764,"about_ca_system_score_gemma":0.003991592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005009802,"about_ca_topic_score_gemma":0.00000649096,"domain_scores_codex":[0.9954538,0.0007501973,0.002278133,0.0005645128,0.0004850991,0.000468212],"domain_scores_gemma":[0.9956497,0.001090239,0.001399652,0.001673149,0.0001141656,0.00007311632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001208737,0.000166941,0.000004313029,0.1519418,0.0002936306,0.0001046337,0.00008155237,2.077956e-9,0.000003208985,0.001001138,0.007746084,0.8386446],"study_design_scores_gemma":[0.001121669,0.0002630296,0.000002413157,0.298613,0.0001602551,0.001904994,0.000007193531,2.077945e-7,0.00003341417,0.0000175583,0.6977192,0.0001570269],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006537613,0.992752,0.000004550406,0.0006017303,0.0002207683,0.003373649,0.00002293821,0.0000194491,0.002998359],"genre_scores_gemma":[0.00001228315,0.9975899,0.0001925024,0.0007758365,0.0002111947,0.0008516969,0.0001159261,0.00007580711,0.000174827],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8384876,"threshold_uncertainty_score":0.9999408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0426814344624905,"score_gpt":0.3878331396155106,"score_spread":0.3451517051530201,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}